Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/47068, first published .
The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review

The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review

The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review

Journals

  1. Phillips B. Towards evidence-based medicine for paediatricians. Archives of Disease in Childhood 2024;109(2):167.2 View
  2. Dong F, Guo W, Liu J, Patterson T, Hong H. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices. Frontiers in Public Health 2024;12 View
  3. Golder S, O'Connor K, Wang Y, Klein A, Gonzalez Hernandez G. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review. JMIR Public Health and Surveillance 2024;10:e59167 View
  4. Liguori V, Anatriello A, Cantone A, Nicoletti M, Argenziano G, Scavone C, Pieretti G. The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System. Aesthetic Plastic Surgery 2025;49(7):2032 View
  5. Dong F, Guo W, Liu J, Patterson T, Hong H. Pharmacovigilance in the digital age: gaining insight from social media data. Experimental Biology and Medicine 2025;250 View

Books/Policy Documents

  1. Berkowitz J, Weissenbacher D, Srinivasan A, Friedrich N, Cortina J, Kivelson S, Hernandez G, Tatonetti N. Artificial Intelligence in Medicine. View
  2. Fartit H, El-Allaly E, Bekri A. International Conference on Advanced Intelligent Systems for Sustainable Development (AI2SD 2024). View